We are proud to announce the expansion of our anticonvulsant therapeutic drug monitoring (TDM) offering to enhance personalized pharmacotherapy. Click here to view PDF
Menu
We are proud to announce the expansion of our anticonvulsant therapeutic drug monitoring (TDM) offering to enhance personalized pharmacotherapy. Click here to view PDF
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during April 2024. Click here to view PDF